Bio-Thera Solutions,Ltd. Financials

Market Capitalization CN¥8.68 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	-19.60
Forward PE	-59.89
Price to Sales TTM	CN¥10.52
Price to Book MRQ	CN¥10.24
Enterprise to Revenue	10.91
Enterprise to EBITDA	-22.99

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	-45.77%
Operating Margin	-70.94%
Return on Assets TTM	-12.62%
Return on Equity TTM	-36.45%

Income Statement

Revenue TTM	CN¥825,176,832
Revenue per Share TTM	CN¥1.99
Quarterly Revenue Growth	22.40%
Gross Profit TTM	CN¥511,495,690
EBITDA	CN¥-391,512,032
Net Income to Common TTM	CN¥-377,670,560
Diluted EPS TTM	CN¥-0.91
Quarterly Earnings Growth YoY	22.38%

Balance Sheet

Total Cash MRQ	CN¥451,098,080
Total Cash per Share MRQ	CN¥1.09
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	82.85
Current Ratio MRQ	0.95
Book Value per Share MRQ	CN¥2.05

Cash Flow

Operating Cash Flow TTM	CN¥-186,355,152
Levered Free Cash Flow TTM	CN¥-347,261,280

688177 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	414,080,000
Float Shares	106,103,859
Avg 10 Volume	2,207,529
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	74.05%
% Held by Institutions	10.27%

Stock Price Summary

Beta	0.47
Fifty Two Week Low	CN¥17.70
Fifty Two Week High	CN¥41.50
Fifty Two Week Change	-83.67%
Day 50 MA	CN¥22.87
Day 200 MA	CN¥25.76

Dividends and Splits

Forward Annual Dividend Rate	CN¥
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	CN¥0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date